There was an overall trend toward a higher percentage of patients reaching the primary end points in the CEST group, but the differences did not reach statistical significance.
← all excerpts
NOR-SASS (Norwegian Sonothrombolysis in Acute Stroke Study): Randomized Controlled Contrast-Enhanced Sonothrombolysis in an Unselected Acute Ischemic Stroke Population.
1
—
—